BIO-TECHNE Corp (TECH) stock
TECHNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q/A on Nov 12, 2026Score 12/3051% above fair value
$72.63−0.16 (-0.22%)
Close on Nov 17, 2026Market cap $11.41BP/E 62.6Yield 0.44%
Bio-Techne free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Bio-Techne's free cash flow for the twelve months ending Jun 30, 2026 was $263.22M, up 2.6% year over year. For fiscal 2026 it was $263.22M, up 2.6% from the year before. Over ten years it grew 7.5% a year on average. The highest annual figure on record is $307.86M in fiscal 2021.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $263.22M | +2.6% |
| FY2025 | Jun 30, 2025 | $256.55M | +8.7% |
| FY2024 | Jun 30, 2024 | $236.10M | +9.2% |
| FY2023 | Jun 30, 2023 | $216.15M | -22.9% |
| FY2022 | Jun 30, 2022 | $280.36M | -8.9% |
| FY2021 | Jun 30, 2021 | $307.86M | +100.6% |
| FY2020 | Jun 30, 2020 | $153.47M | -1.8% |
| FY2019 | Jun 30, 2019 | $156.21M | +4.5% |
| FY2018 | Jun 30, 2018 | $149.43M | +16.3% |
| FY2017 | Jun 30, 2017 | $128.54M | +1.0% |
| FY2016 | Jun 30, 2016 | $127.26M | +6.5% |
| FY2015 | Jun 30, 2015 | $119.45M | -2.8% |
| FY2014 | Jun 30, 2014 | $122.94M | +21.6% |
| FY2013 | Jun 30, 2013 | $101.11M | -16.3% |
| FY2012 | Jun 30, 2012 | $120.73M | -2.3% |
| FY2011 | Jun 30, 2011 | $123.56M | +15.9% |
| FY2010 | Jun 30, 2010 | $106.62M | +1.8% |
| FY2009 | Jun 30, 2009 | $104.77M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $86.94M | -6.8% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $77.58M | +150.3% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $76.49M | -1.3% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $22.22M | -59.4% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $93.31M | +62.2% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $31.00M | -52.0% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $77.53M | +13.6% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $54.72M | +19.5% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $57.52M | -20.7% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $64.55M | +66.4% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $68.25M | +17.1% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $45.79M | -1.6% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $72.56M | -18.6% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $38.79M | -33.2% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $58.28M | -35.8% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $46.53M | +9.8% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $89.15M | -19.5% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $58.03M | -9.7% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $90.83M | +16.7% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $42.36M | -23.1% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $110.70M | +303.8% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $64.26M | +59.9% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $77.82M | +39.3% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $55.07M | +83.5% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $27.42M | -38.0% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $40.19M | +15.7% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $55.85M | +33.1% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $30.01M | -14.9% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $44.25M | -25.0% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $34.74M | +91.5% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $41.96M | +27.7% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $35.26M | -10.6% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $59.02M | +31.2% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $18.14M | -13.6% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $32.85M | -14.7% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $39.42M | +63.9% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $44.98M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $21.00M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $38.50M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $24.06M | – |
See a number that looks wrong?